BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 31115933)

  • 1. Short-term and long-term impacts of Helicobacter pylori eradication with reverse hybrid therapy on the gut microbiota.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Chen YH; Tsai TJ; Wu DC; Tsai KW
    J Gastroenterol Hepatol; 2019 Nov; 34(11):1968-1976. PubMed ID: 31115933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication with bismuth quadruple therapy leads to dysbiosis of gut microbiota with an increased relative abundance of Proteobacteria and decreased relative abundances of Bacteroidetes and Actinobacteria.
    Hsu PI; Pan CY; Kao JY; Tsay FW; Peng NJ; Kao SS; Wang HM; Tsai TJ; Wu DC; Chen CL; Tsai KW;
    Helicobacter; 2018 Aug; 23(4):e12498. PubMed ID: 29897654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term changes in the gut microbiota after 14-day bismuth quadruple therapy in penicillin-allergic children.
    Zhou Y; Ye Z; Lu J; Miao S; Lu X; Sun H; Wu J; Wang Y; Huang Y
    Helicobacter; 2020 Oct; 25(5):e12721. PubMed ID: 32656891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term changes of gut microbiota, antibiotic resistance, and metabolic parameters after Helicobacter pylori eradication: a multicentre, open-label, randomised trial.
    Liou JM; Chen CC; Chang CM; Fang YJ; Bair MJ; Chen PY; Chang CY; Hsu YC; Chen MJ; Chen CC; Lee JY; Yang TH; Luo JC; Chen CY; Hsu WF; Chen YN; Wu JY; Lin JT; Lu TP; Chuang EY; El-Omar EM; Wu MS;
    Lancet Infect Dis; 2019 Oct; 19(10):1109-1120. PubMed ID: 31559966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Effect of Probiotics on Gut Microbiota during the Helicobacter pylori Eradication: Randomized Controlled Trial.
    Oh B; Kim BS; Kim JW; Kim JS; Koh SJ; Kim BG; Lee KL; Chun J
    Helicobacter; 2016 Jun; 21(3):165-74. PubMed ID: 26395781
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term changes in the gut microbiota after triple therapy, sequential therapy, bismuth quadruple therapy and concomitant therapy for Helicobacter pylori eradication in Chinese children.
    Zhou Y; Ye Z; Wang Y; Huang Z; Zheng C; Shi J; Tang W; Zhang P; Wang S; Huang Y
    Helicobacter; 2021 Aug; 26(4):e12809. PubMed ID: 33899288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The eradication of Helicobacter pylori restores rather than disturbs the gastrointestinal microbiota in asymptomatic young adults.
    He C; Peng C; Wang H; Ouyang Y; Zhu Z; Shu X; Zhu Y; Lu N
    Helicobacter; 2019 Aug; 24(4):e12590. PubMed ID: 31124220
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-day high-dose proton pump inhibitor triple therapy versus sequential therapy for Helicobacter pylori eradication.
    Auesomwang C; Maneerattanaporn M; Chey WD; Kiratisin P; Leelakusolwong S; Tanwandee T
    J Gastroenterol Hepatol; 2018 Nov; 33(11):1822-1828. PubMed ID: 29804294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. H. pylori eradication with antibiotic treatment causes changes in glucose homeostasis related to modifications in the gut microbiota.
    Martín-Núñez GM; Cornejo-Pareja I; Coin-Aragüez L; Roca-Rodríguez MDM; Muñoz-Garach A; Clemente-Postigo M; Cardona F; Moreno-Indias I; Tinahones FJ
    PLoS One; 2019; 14(3):e0213548. PubMed ID: 30870471
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower impact of vonoprazan-amoxicillin dual therapy on gut microbiota for Helicobacter pylori eradication.
    Horii T; Suzuki S; Takano C; Shibuya H; Ichijima R; Kusano C; Ikehara H; Gotoda T
    J Gastroenterol Hepatol; 2021 Dec; 36(12):3314-3321. PubMed ID: 34107551
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of Helicobacter pylori infection and its long-term impacts on gut microbiota.
    Liou JM; Lee YC; Wu MS
    J Gastroenterol Hepatol; 2020 Jul; 35(7):1107-1116. PubMed ID: 31984532
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Gut Microbiota and
    Gao JJ; Zhang Y; Gerhard M; Mejias-Luque R; Zhang L; Vieth M; Ma JL; Bajbouj M; Suchanek S; Liu WD; Ulm K; Quante M; Li ZX; Zhou T; Schmid R; Classen M; Li WQ; You WC; Pan KF
    Front Cell Infect Microbiol; 2018; 8():202. PubMed ID: 29971220
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    Yang L; Zhang J; Xu J; Wei X; Yang J; Liu Y; Li H; Zhao C; Wang Y; Zhang L; Gai Z
    Front Cell Infect Microbiol; 2019; 9():375. PubMed ID: 31781514
    [No Abstract]   [Full Text] [Related]  

  • 14. Dynamic changes in antibiotic resistance genes and gut microbiota after Helicobacter pylori eradication therapies.
    Wang L; Yao H; Tong T; Lau K; Leung SY; Ho JWK; Leung WK
    Helicobacter; 2022 Apr; 27(2):e12871. PubMed ID: 34969161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gut microbiome can be restored without adverse events after Helicobacter pylori eradication therapy in teenagers.
    Gotoda T; Takano C; Kusano C; Suzuki S; Ikehara H; Hayakawa S; Andoh A
    Helicobacter; 2018 Dec; 23(6):e12541. PubMed ID: 30311721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal microbiome and
    Sitkin S; Lazebnik L; Avalueva E; Kononova S; Vakhitov T
    World J Gastroenterol; 2022 Feb; 28(7):766-774. PubMed ID: 35317277
    [No Abstract]   [Full Text] [Related]  

  • 17. Helicobacter pylori Eradication Causes Perturbation of the Human Gut Microbiome in Young Adults.
    Yap TW; Gan HM; Lee YP; Leow AH; Azmi AN; Francois F; Perez-Perez GI; Loke MF; Goh KL; Vadivelu J
    PLoS One; 2016; 11(3):e0151893. PubMed ID: 26991500
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long term impact of vonoprazan-based Helicobacter pylori treatment on gut microbiota and its relation to post-treatment body weight changes.
    Suzuki S; Gotoda T; Takano C; Horii T; Sugita T; Ogura K; Ichijima R; Kusano C; Ikehara H
    Helicobacter; 2021 Dec; 26(6):e12851. PubMed ID: 34486195
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Concomitant and hybrid therapy for Helicobacter pylori infection: A randomized clinical trial.
    Heo J; Jeon SW; Jung JT; Kwon JG; Lee DW; Kim HS; Yang CH; Park JB; Park KS; Cho KB; Lee SH; Jang BI;
    J Gastroenterol Hepatol; 2015 Sep; 30(9):1361-6. PubMed ID: 25867608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of
    Iino C; Shimoyama T
    World J Gastroenterol; 2021 Oct; 27(37):6224-6230. PubMed ID: 34712028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.